BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25155598)

  • 1. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.
    Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9.
    Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S
    Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron chelators ICL670 and 311 inhibit HIV-1 transcription.
    Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S
    Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.
    Charles S; Ammosova T; Cardenas J; Foster A; Rotimi J; Jerebtsova M; Ayodeji AA; Niu X; Ray PE; Gordeuk VR; Kashanchi F; Nekhai S
    J Cell Physiol; 2009 Nov; 221(2):469-79. PubMed ID: 19626680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.
    Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S
    Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
    Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
    J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.
    Lin X; Ammosova T; Kumari N; Nekhai S
    Curr Pharm Des; 2017; 23(28):4122-4132. PubMed ID: 28677499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner.
    Khan SZ; Mitra D
    J Biol Chem; 2011 Jul; 286(26):22943-54. PubMed ID: 21555514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.
    Ramakrishnan R; Liu H; Donahue H; Malovannaya A; Qin J; Rice AP
    Retrovirology; 2012 Oct; 9():90. PubMed ID: 23110726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
    Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.
    Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S
    Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.